Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
| Distributed by / for | Hikma Injectables USA Inc |
| NDC | 63037-137-25 |
| Full product label | ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill in a 3mL pre-filled syringe, For IV or IM Use, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, This is a Compounded Drug. Hospital/Office Use Only. NDC 63037-137-25 |
| Recalling firm | Hikma Injectables USA Inc |
| Distribution | Nationwide in the USA |
| Quantity | 1,800 syringes |
| Recall initiated | 2024-12-19 |
| Report date | 2025-01-08 |
| Recall completed | 2025-11-12 |
| Recall number | D-0173-2025 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Dayton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗